Urogen Pharma Ltd (URGN)

Operating Cash Flow Growth

17.12%

Quarterly · Period ending:

URGN logo

URGN Operating Cash Flow Growth

Year-over-year change vs the same period a year earlier

Latest reported17.12%
URGN Quarterly Cash from Operations YoY % (-19.04% → 17.12%)
High-resolution chart · PNG

URGN operating cash flow growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Urogen Pharma Ltd Operating Cash Flow Growth — Quarterly
Period endingOperating Cash Flow Growth
17.1224%
-7.8336%
-181.4083%
-52.7979%
-67.6983%
-32.4216%
-4.3125%
-59.9168%
-17.1352%
-22.9705%
39.9781%
-3.5866%
16.2197%
-7.5471%
-8.3807%
9.6123%
-27.7329%
12.4266%
5.5174%
26.3317%
20.8283%
23.1065%
18.3%
-100.1916%
-64.404%
-98.7008%
-152.8199%
-35.0145%
-78.6547%
-86.3466%
-72.4925%
-457.2969%
-135.3944%
-250.6011%
-144.6726%
173.6529%
-15.3667%
-4.333%
978.6043%
-97.6709%
-19.0439%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.